AbbVie Inc. - Dividend History
4AB.DE
Price:
$206
Market Cap:
$415.00B
AbbVie Inc. is a global biopharmaceutical enterprise focused on the discovery, development, production, and worldwide commercialization of pharmaceutical remedies. Its diverse product portfolio targets a wide range of health conditions. Key offerings include HUMIRA, an injectable treatment for autoimmune and intestinal Behçet's diseases; SKYRIZI, indicated for moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor utilized in adults with moderate to severe active rheumatoid arthritis. In oncology, AbbVie provides IMBRUVICA for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), as well as VENCLEXTA, a BCL-2 inhibitor also for adult...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2016-05-17
Stock Exchange
XETRA
Ticker
4AB.DE
PE Ratio
[36.07]
ROE
[68.01%]
Current Ratio
[0.80]
Dividend Yield
[2.87%]
Enterprise Value
[478.47B]
Dividend History
4AB.DE Dividend History Overview
Dividends are a key part of long-term returns for investors, and AbbVie Inc. (4AB.DE) has a track record worth reviewing. Looking at dividend history for 4AB.DE gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-07-15
Dividend Yield
2.87%
Annual Dividend
$1.51
P/E Ratio
36.07
Payout Ratio
3.25
Dividend per Share
$6.74
EPS
5.71
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-07-15 | $1.51388 | $1.51388 | 2026-08-14 | |
| 2026-04-15 | $1.46641 | $1.46641 | 2026-05-15 | |
| 2026-01-16 | $1.475 | $1.475 | 2026-02-17 | |
| 2025-10-15 | $1.39826 | $1.39826 | 2025-11-14 | |
| 2025-07-15 | $1.39744 | $1.39744 | 2025-08-15 | |
| 2025-04-15 | $1.39826 | $1.39826 | 2025-05-15 | |
| 2025-01-15 | $1.5931 | $1.5931 | 2025-02-14 | 2025-01-15 |
| 2024-10-15 | $1.42058 | $1.42058 | 2024-11-15 | 2024-10-15 |
| 2024-07-15 | $1.55 | $1.55 | 2024-08-15 | |
| 2024-04-12 | $1.55 | $1.55 | 2024-05-15 | |
| 2024-01-12 | $1.55 | $1.55 | 2024-02-15 |
AbbVie Inc. (4AB.DE) Dividend History Chart
The table below shows AbbVie Inc. (4AB.DE) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
AbbVie Inc. (4AB.DE) Dividend Growth
AbbVie Inc. (4AB.DE) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Johnson & Johnson (JNJ.DE) | 0.02% |
| AstraZeneca PLC (ZEG.DE) | 0.02% |
| Merck & Co., Inc. (6MK.DE) | 0.03% |
| Amgen Inc. (AMG.DE) | 0.03% |
| UnitedHealth Group Incorporated (UNH.DE) | 0.02% |
| Gilead Sciences, Inc. (GIS.DE) | 0.03% |
| Bristol-Myers Squibb Company (BRM.DE) | 0.05% |
| Pfizer Inc. (PFE.F) | 0.07% |
| Pfizer Inc. (PFE.DE) | 0.07% |
| Sanofi (SNW.DE) | 0.06% |
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like AbbVie Inc. (4AB.DE) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is 4AB.DE’s dividend yield?
What is the difference between regular and special dividends?
Has 4AB.DE increased its dividends over time?
Why might dividend history data be delayed?
How often does 4AB.DE pay dividends?
What factors impact 4AB.DE's dividend payments?
Can dividends change over time?
What is 4AB.DE’s next dividend date?